» Articles » PMID: 37309557

Comparison of Corneal Epithelial Wound Healing Between Topical RCI001, Solcoseryl, and Polydeoxyribonucleotide in the Murine Ocular Alkali Burn Model

Overview
Specialty Ophthalmology
Date 2023 Jun 13
PMID 37309557
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the corneal epithelial wound healing effects of RCI001, Solcoseryl, and polydeoxyribonucleotide (PDRN) in a rat alkali burn model.

Methods: In 40 male Sprague-Dawley rats, we induced alkali burn using filter paper soaked in 0.2N sodium hydroxide. The rats were then treated with topical 0.5% RCI001, 1.0% RCI001, Solcoseryl, or PDRN twice a day for 2 weeks. Corneal epithelial integrity and epithelial healing rate were measured at day 0, 3, 5, 7, 10, and 14. Histologic and immunohistochemistry findings were also assessed.

Results: Both the 0.5% and 1.0% RCI001 groups showed significantly more epithelial healing compared to the control group at day 5, 7, 10, and 14 (each p < 0.05). No statistical difference was found between the 0.5% and 1.0% RCI001 groups. Neither the Solcoseryl nor the PDRN groups showed a significant difference from the control. RCI001 treatment resulted in significantly reduced stromal edema, and a trend towards less inflammatory cell infiltration.

Conclusions: Topical application of RCI001 showed enhanced corneal epithelial wound healing in the murine corneal alkali burn model, presumably by suppressing inflammation. Meanwhile, Solcoseryl and PDRN did not show sufficient therapeutic effects compared to RCI001.

Citing Articles

Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model.

Kang H, Jung Y, Moon J, Ryu J, Yoon C, Kim Y Cornea. 2024; 44(2):226-233.

PMID: 39288434 PMC: 11676593. DOI: 10.1097/ICO.0000000000003696.


Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications.

Volatier T, Cursiefen C, Notara M Cells. 2024; 13(2).

PMID: 38247854 PMC: 10814767. DOI: 10.3390/cells13020163.

References
1.
Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K . Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sci. 2010; 52(1):427-33. DOI: 10.1167/iovs.10-6167. View

2.
Im S, Kim H, Yoon J, Oh J, Kim M, Chung M . Therapeutic Effects of Topical 8-Oxo-2'-deoxyguanosine on Ethanol-Induced Ocular Chemical Injury Models. Cornea. 2018; 37(10):1311-1317. DOI: 10.1097/ICO.0000000000001671. View

3.
Krannig H, STRAUB W . Therapy of corneal erosions and 'dry eye' with Solcoseryl and Vitasic eye drops. Ophthalmologica. 1989; 199(2-3):100-5. DOI: 10.1159/000310024. View

4.
Wilmink J, Stolk P, van Weeren P, Barneveld A . The effectiveness of the haemodialysate Solcoseryl for second-intention wound healing in horses and ponies. J Vet Med A Physiol Pathol Clin Med. 2000; 47(5):311-20. DOI: 10.1046/j.1439-0442.2000.00287.x. View

5.
Huh J, Son D, Lee Y, Lee J, Kim B, Lee H . 8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation. Free Radic Biol Med. 2012; 53(1):109-21. PMC: 5489255. DOI: 10.1016/j.freeradbiomed.2012.03.023. View